塞库金单抗
医学
泛发性脓疱性银屑病
皮肤病科
银屑病
脓疱性银屑病
安全概况
斑块性银屑病
不利影响
内科学
银屑病性关节炎
作者
Lu Xing,L. Long,Tao Wu,Liangyu Yin,Li Yu,Jingnan Wu,D. Li,Limin Miao,Hong Shu
标识
DOI:10.1080/09546634.2024.2443121
摘要
Conclusions: Secukinumab demonstrated long-term efficacy and safety in pediatric GPP, significantly improving clinical outcomes and quality of life, with no serious adverse events reported.
科研通智能强力驱动
Strongly Powered by AbleSci AI